SPONSOR
RenJi Hospital
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Locally Advanced Cervical CarcinomaConcurrent ChemoradiotherapyImmunotherapyIntracranial Hemorrhages
RenJi Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy, Intracranial Hemorrhages.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — RenJi Hospital
How many clinical trials has RenJi Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by RenJi Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does RenJi Hospital research focus on?
RenJi Hospital clinical trials span Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy, Intracranial Hemorrhages. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a RenJi Hospital clinical trial?
To participate in a RenJi Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all RenJi Hospital trials with current recruitment status updated daily.
Clinical Trials by RenJi Hospital
NCT06391190 Phase 1, Phase 2
Recruiting
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
Locally Advanced Cervical Carcinoma
NCT06404645
Recruiting
A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma
Intracranial Hemorrhages
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology